MARKET

HOOK

HOOK

Hookipa Pharma Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.70
+0.06
+0.79%
After Hours: 7.70 0 0.00% 16:00 09/17 EDT
OPEN
7.66
PREV CLOSE
7.64
HIGH
7.82
LOW
7.56
VOLUME
12.15K
TURNOVER
--
52 WEEK HIGH
14.76
52 WEEK LOW
6.06
MARKET CAP
200.78M
P/E (TTM)
-20.9695
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of HOOK and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

HOOK News

  • HOOKIPA Pharma to Present at Upcoming Investor Conferences in September
  • GlobeNewswire.08/29 13:30
  • HOOKIPA Pharma Q2 Net Loss $12.079M vs Loss $5.819M In Same Qtr. Last Year, Sales $4.051M Beat $2.08M Estimate
  • Benzinga.08/12 20:28
  • HOOKIPA Pharma Reports Second Quarter 2019 Financial Results and Clinical Progress Highlights
  • GlobeNewswire.08/12 20:01
  • What Kind Of Shareholders Own HOOKIPA Pharma Inc. (NASDAQ:HOOK)?
  • Simply Wall St..07/19 18:37

More

Industry

Pharmaceuticals
+0.65%
Pharmaceuticals & Medical Research
+0.57%

Hot Stocks

Name
Price
%Change

About HOOK

HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is developing products to prevent and cure infectious diseases and cancer. The Company's infectious and oncology product candidates HB-101, HB-201 and HB-202. The infectious disease product candidate, HB-101, is in a randomized, double-blinded Phase II clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates, HB-201 and HB-202, are in development for the treatment of human papillomavirus-positive cancers. The Company offers VaxWave technology, which is designed to induce a robust CD8+ T cell and pathogen neutralizing response to fight disease. VaxWave technology supports the benefits of our arenavirus platform approach.
More

Webull offers Hookipa Pharma Inc (HOOK) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.